DK327182A - WRAPPED POLYOXIDES AND PROCEDURES FOR PREPARING THEREOF - Google Patents
WRAPPED POLYOXIDES AND PROCEDURES FOR PREPARING THEREOF Download PDFInfo
- Publication number
- DK327182A DK327182A DK327182A DK327182A DK327182A DK 327182 A DK327182 A DK 327182A DK 327182 A DK327182 A DK 327182A DK 327182 A DK327182 A DK 327182A DK 327182 A DK327182 A DK 327182A
- Authority
- DK
- Denmark
- Prior art keywords
- capsular
- polyosides
- bacteriae
- give
- retained material
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0266—Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Polyesters Or Polycarbonates (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) Process for the production of immunogenic capsular polyosides from capsulated bacteriae containing same, characterised in that it consists in cultivating the bacteriae in a synthetic medium which may contain up to about 0.5% by weight of naturally occuring materials ; at the end of the growth stage of said culture removing the microbial bodies, submitting the liquid phase after removal of the microbial bodies to a filtration through a membrane which retains the molecules of a molecular weight of 100 000 daltons or more, to give a capsular polyosides-rich retained material ; and removing the proteins, the nucleic acids and the lipids from said retained material, to give a purified capsular polyoside. 1. Claims (for the Contracting State AT) Process for the production of immunogenic capsular polyosides from capsulated bacteriae containing same, characterised in that it consists in cultivating the bacteriae in a synthetic medium which may contain up to about 0.5% by weight of naturally occuring materials ; at the end of the growth stage of said culture removing the microbial bodies, submitting the liquid phase after removal of the microbial bodies to a filtration through a membrane which retains the molecules of a molecular weight of 100 000 daltons or more, to give a capsular polyosides-rich retained material ; and removing the proteins, the nucleic acids and the lipids from said retained material, to give a purified capsular polyoside.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8114842A FR2510606A1 (en) | 1981-07-30 | 1981-07-30 | PROCESS FOR OBTAINING CAPSULAR POLYOSIDES, CAPSULAR POLYOSIDES THUS OBTAINED AND THEIR APPLICATION TO THE PREPARATION OF VACCINES |
Publications (1)
Publication Number | Publication Date |
---|---|
DK327182A true DK327182A (en) | 1983-01-31 |
Family
ID=9261011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK327182A DK327182A (en) | 1981-07-30 | 1982-07-21 | WRAPPED POLYOXIDES AND PROCEDURES FOR PREPARING THEREOF |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0071515B1 (en) |
AT (1) | ATE16244T1 (en) |
CA (1) | CA1206905A (en) |
DD (1) | DD202623A5 (en) |
DE (1) | DE3267160D1 (en) |
DK (1) | DK327182A (en) |
ES (1) | ES8305827A1 (en) |
FR (1) | FR2510606A1 (en) |
IE (1) | IE53582B1 (en) |
NO (1) | NO159394C (en) |
PT (1) | PT75301B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3683844D1 (en) * | 1986-03-27 | 1992-03-19 | Schweiz Serum & Impfinst | VACCINE OF KLEBSIELLA CAPSULPOLYSACCHARID. |
US6426074B1 (en) * | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
KR100914702B1 (en) * | 2000-03-16 | 2009-08-28 | 더 칠드런스 호스피탈 오브 필라델피아 | Modulating production of pneumococcal capsular polysaccharide |
NZ511680A (en) | 2001-05-14 | 2004-07-30 | Univ Waikato | Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases |
GB0522303D0 (en) * | 2005-11-01 | 2005-12-07 | Chiron Srl | Culture method |
US8398985B2 (en) | 2007-04-23 | 2013-03-19 | Serum Institute Of India Ltd. | Antigenic polysaccharides and process for their preparation |
WO2011148382A1 (en) | 2010-05-28 | 2011-12-01 | Biological E Limited | An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol. |
WO2011151841A1 (en) * | 2010-05-31 | 2011-12-08 | Panacea Biotec Limited | Fermentation process for streptococcus pneumoniae |
US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
EP3562503A2 (en) | 2016-12-30 | 2019-11-06 | Sutrovax, Inc. | Polypeptide-antigen conjugates with non-natural amino acids |
WO2020010016A1 (en) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Self-adjuvanted immunogenic conjugates |
WO2024062494A1 (en) | 2022-09-19 | 2024-03-28 | Biological E Limited | Method for the purification of capsular polysaccharides |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2166963A (en) * | 1936-11-19 | 1939-07-25 | Sharp & Dohme Inc | Antigenic polysaccharide complex |
US2528972A (en) * | 1947-05-15 | 1950-11-07 | Western Reserve University | Prophylactic toxoid compound and method of making same |
FR2407262A1 (en) * | 1977-10-27 | 1979-05-25 | Cassenne Lab Sa | NEW POLYSACCHARIDES MICROBIAL BODY EXTRACTS OF HAEMOPHILUS INFLUENZAE, PROCESS FOR THE PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS OF THESE NEW PRODUCTS |
CA1115210A (en) * | 1977-11-28 | 1981-12-29 | Dennis J. Carlo | Pneumococcal vaccine |
US4264764A (en) * | 1979-01-12 | 1981-04-28 | Merck & Co., Inc. | Meningitis vaccine |
US4221906A (en) * | 1979-03-19 | 1980-09-09 | American Cyanamid Company | Stabilization of pneumococcal polysaccharides |
US4287173A (en) * | 1979-09-24 | 1981-09-01 | Merck & Co., Inc. | Vaccine for dental caries |
US4307080A (en) * | 1979-09-24 | 1981-12-22 | Merck & Co., Inc. | Meningitis vaccine |
-
1981
- 1981-07-30 FR FR8114842A patent/FR2510606A1/en active Granted
-
1982
- 1982-07-15 IE IE1705/82A patent/IE53582B1/en unknown
- 1982-07-19 AT AT82401343T patent/ATE16244T1/en not_active IP Right Cessation
- 1982-07-19 DE DE8282401343T patent/DE3267160D1/en not_active Expired
- 1982-07-19 EP EP82401343A patent/EP0071515B1/en not_active Expired
- 1982-07-21 DK DK327182A patent/DK327182A/en not_active Application Discontinuation
- 1982-07-23 PT PT75301A patent/PT75301B/en not_active IP Right Cessation
- 1982-07-28 CA CA000408233A patent/CA1206905A/en not_active Expired
- 1982-07-28 NO NO822592A patent/NO159394C/en unknown
- 1982-07-29 ES ES514496A patent/ES8305827A1/en not_active Expired
- 1982-07-29 DD DD82242065A patent/DD202623A5/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO822592L (en) | 1983-01-31 |
DE3267160D1 (en) | 1985-12-05 |
IE821705L (en) | 1983-01-30 |
EP0071515B1 (en) | 1985-10-30 |
ES514496A0 (en) | 1983-04-16 |
ATE16244T1 (en) | 1985-11-15 |
DD202623A5 (en) | 1983-09-28 |
ES8305827A1 (en) | 1983-04-16 |
EP0071515A1 (en) | 1983-02-09 |
PT75301B (en) | 1984-07-31 |
NO159394C (en) | 1988-12-21 |
FR2510606B1 (en) | 1984-10-26 |
NO159394B (en) | 1988-09-12 |
IE53582B1 (en) | 1988-12-21 |
CA1206905A (en) | 1986-07-02 |
FR2510606A1 (en) | 1983-02-04 |
PT75301A (en) | 1982-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK327182A (en) | WRAPPED POLYOXIDES AND PROCEDURES FOR PREPARING THEREOF | |
IL84699A (en) | Process for transforming plant protoplasts | |
ATE91155T1 (en) | PROCESS FOR PREPARING NUCLEIC ACID FOR HYBRIDIZATION. | |
DE69112463D1 (en) | Device for the production of monocrystals according to the Czochralski process. | |
ES8505818A1 (en) | Method for the production of HA fraction containing protective antigens of Bordetella pertussis and pertussis vaccine. | |
ES8600401A1 (en) | New furanone derivatives, process for the preparation thereof and use thereof. | |
DE69109886D1 (en) | Process for the preparation of human factor VIII and its analogs. | |
DK232483A (en) | PROCEDURE FOR MANUFACTURING WS 6049 CONNECTIONS | |
FR2545099B1 (en) | NOVEL STRAIN OF TRICHODERMA HARZIANUM METHOD FOR ISOLATING THIS STRAIN, METHOD FOR CULTURING THIS STRAIN, NEW PEPTIDES PRODUCED BY THIS STRAIN, AND APPLICATION OF THIS STRAIN AND THESE NEW PEPTIDES OR THE PRODUCT OBTAINED BY THE CULTURE PROCESS AS A MEANS OF BIOLOGY IN THE FORM OF A PHYTOSANITARY PRODUCT | |
DE3860798D1 (en) | POROESES PRODUCT FOR PLANT CULTURE AND METHOD FOR THE PRODUCTION THEREOF. | |
DE3584610D1 (en) | LIVING MICRO-ORGANISMS CONTAINING LIQUID PREPARATION, METHOD FOR THE PRODUCTION THEREOF, LIVING MICRO-ORGANISMS CONTAINING PELLETED PRODUCT AND METHOD FOR THE PRODUCTION THEREOF. | |
DE69325449D1 (en) | METHOD FOR DEVELOPING NEW PLANT TYPES WITH CAPACITY FOR BONDING NITROGEN ALSO IN THE LEAVES | |
DE3065316D1 (en) | Process for the production of creatinine iminohydrolase by growing micro-organism and nutrient medium for the practice of said process | |
ATE9100T1 (en) | TRICHOSPORON KASHIWAYAMA IFO 1964, CULTURE BROTH, CELL-FREE STERILE LIQUID, STERILE FILTRATE, STERILE SUPERNATANT, STERILE CONCENTRATE AND STERILE DRY PRODUCT OF CULTURE BROTH, PROCESS FOR PREPARATION OF CULTURE BROTH, PHARMACEUTICAL COMPOSITION, COSMETIC TO COMPOSITION. | |
ATE1235T1 (en) | NEW M-ANILIDURETHANES, HERBICIDES CONTAINING THEM AND PROCESSES FOR THEIR PRODUCTION, AND METHODS FOR CONTROLLING UNDESIRABLE PLANT GROWTH. | |
FR2641938B3 (en) | PLATE-LIKE GROUNDLESS GROWING MEDIUM FOR GROWING PLANTS | |
ATE21033T1 (en) | PROCESS FOR THE PRODUCTION OF AN IMMUNOGEN FROM PASTEURELLA MULTOCIDA. | |
FR2338256A1 (en) | NEW ARYLOXY (THIO) CARBONYLAMINOMETHYL ESTERS OF PHENOXYCARBOXYLIC ACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS PLANT GROWTH SUBSTANCES | |
DE3677217D1 (en) | METHOD FOR REGENERATING CORN. | |
JPS5675095A (en) | Preparation of heat-resistant acetic acid kinase | |
EP0337625A3 (en) | Probes | |
RU93028311A (en) | METHOD FOR PRODUCING BIOLOGICALLY ACTIVE SUBSTANCES FROM BIOMASS OF CULTIVATED PLANT CELLS | |
RU94025893A (en) | Method of isolation of biologically active substances | |
JPS5682095A (en) | Purification of fatty acid produced through fermentation process | |
FR2655659B1 (en) | PROCESS FOR INHIBITING THE GROWTH OF MICROORGANISMS IN A CULTURE MEDIUM BEFORE ITS USE, THE MEDIUM THUS OBTAINED AND ITS APPLICATION TO THE CULTURE OF BIFIDOBACTERIA. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |